Company Badge
USPTO Data Jan 1 1976 - Oct 27 2026
9 Patents
#181 in Toronto
#1,705 in Canada
Ripple Therapeutics Corporation
Forward Citations = 16
18 inventors:
Ripple Therapeutics Corporation
Calculating rank
Trademarks = 1
Forward Citations = 16
Loading Chart...
Loading Chart...
18 inventors (with patents filed for the assignee):
Ian Charles Parrag (9 out of 9 patents)
Matthew Alexander John Statham (8 out of 8 patents)
Wendy Alison Naimark (7 out of 8 patents)
4. Kyle Giovanni Battiston (7 out of 8 patents)
5. Hans Christian Fischer (6 out of 8 patents)
6. Dimitra Louka (6 out of 6 patents)
7. Paul Joseph Santerre (4 out of 38 patents)
8. Georgios Rizis (2 out of 3 patents)
9. Bahareh Khalili (1 out of 11 patents)
10. Leonard Pinchuk (1 out of 149 patents)
11. Boris Gorin (1 out of 32 patents)
12. Roseita Esfand (1 out of 12 patents)
13. Jared A Demorat (1 out of 1 patent)
14. Robert William Henson (1 out of 1 patent)
15. Eli B Nichols (1 out of 1 patent)
9 patents:
1. 12509469 - Compositions and methods for the treatment of pain and dependence disorders (2025-12-30),
Company Overview
Ripple Therapeutics Corporation is a biotech company focused on developing innovative therapies for ophthalmic and dermatologic diseases. Utilizing a proprietary platform technology, Ripple Therapeutics is advancing novel drug delivery solutions to improve patient outcomes and treatment options. With a strong emphasis on research and development, the company is dedicated to addressing unmet medical needs in the field of ophthalmology and dermatology.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Ripple Therapeutics Corporation. Retrieved from https://idiyas.com/company/ripple-therapeutics
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]